During the past decade, I Klinika Choroby Wiencowej conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "I Klinika Choroby Wiencowej" are "Acute Myocardial Infarction" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "I Klinika Choroby Wiencowej" in a lesser frequency.

Most popular intervention types in "I Klinika Choroby Wiencowej" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pexelizumab" (1 trials), "Placebo infusion" (1 trials) and "Tolvaptan" (1 trials). Other intervention names were less common.

The vast majority of trials in "I Klinika Choroby Wiencowej" are 2 trials for "All" genders.

Currently, there are NaN active trials in "I Klinika Choroby Wiencowej". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in I Klinika Choroby Wiencowej, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in I Klinika Choroby Wiencowej, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".